Literature DB >> 30926076

10-day vs 5-day decitabine: equivalence cannot be concluded.

Gerwin Huls1, Stefan Suciu2, Pierre Wijermans3, Michal Kicinski2, Michael Lübbert4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30926076     DOI： 10.1016/S2352-3026(19)30024-9

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN： 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  1 in total

1.  Efficacy of 10-day decitabine in acute myeloid leukemia.

Authors:  Ian M Bouligny; Vivek Mehta; Scott Isom; Leslie R Ellis; Rupali R Bhave; Dianna S Howard; Susan Lyerly; Megan Manuel; Sarah Dralle; Bayard L Powell; Timothy S Pardee
Journal:  Leuk Res       Date:  2021-02-12       Impact factor: 3.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.